Pixantrone: a novel anthracycline-like drug for the treatment of non-Hodgkin lymphoma
出版年份 2015 全文链接
标题
Pixantrone: a novel anthracycline-like drug for the treatment of non-Hodgkin lymphoma
作者
关键词
-
出版物
Expert Opinion On Drug Safety
Volume 14, Issue 4, Pages 601-607
出版商
Informa Healthcare
发表日期
2015-02-26
DOI
10.1517/14740338.2015.1010505
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bortezomib for the treatment of non-Hodgkin’s lymphoma
- (2014) Prithviraj Bose et al. EXPERT OPINION ON PHARMACOTHERAPY
- Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma
- (2014) S. Limat et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Tolerability and toxicological profile of pixantrone (Pixuvri®) in juvenile mice. Comparative study with doxorubicin
- (2014) Monica Longo et al. REPRODUCTIVE TOXICOLOGY
- Comparison of pixantrone-based regimen (CPOP-R) with doxorubicin-based therapy (CHOP-R) for treatment of diffuse large B-cell lymphoma
- (2013) R. Herbrecht et al. ANNALS OF ONCOLOGY
- The European Medicines Agency Review of Pixantrone for the Treatment of Adult Patients With Multiply Relapsed or Refractory Aggressive Non-Hodgkin's B-Cell Lymphomas: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
- (2013) E. Pean et al. ONCOLOGIST
- Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin’s lymphoma patients
- (2012) Luigi Rigacci et al. ANNALS OF HEMATOLOGY
- Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)
- (2012) N. Ketterer et al. ANNALS OF ONCOLOGY
- Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial
- (2012) Ruth Pettengell et al. LANCET ONCOLOGY
- Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma
- (2011) Tomasz P. Srokowski et al. CANCER
- Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group
- (2011) Javier G. Blanco et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lymphoma
- (2011) Peter Borchmann et al. LEUKEMIA & LYMPHOMA
- Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
- (2010) B. Coiffier et al. BLOOD
- Phase II Study of Dose-Adjusted EPOCH and Rituximab in Untreated Diffuse Large B-Cell Lymphoma With Analysis of Germinal Center and Post-Germinal Center Biomarkers
- (2008) Wyndham H. Wilson et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started